Home | All results_reference

[RDF data]
Results Reference #1230

Resource URI: http://static.linkedct.org/resource/results_reference/1230
linkedct:citation Moore MJ, Goldstein D, Hamm J, et al.: Erlotinib improves survival when added to gemcitabine in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG]. [Abstract] American Society of Clinical Oncology 2005 Gastrointestinal Cancers Symposium, 27-29 January 2005, Miami, Florida. A-77, 2005.
rdfs:label Results Reference #1230
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00026338>
linkedct:results_reference_id 1230 (xsd:int)
rdf:type linkedct:results_reference